Strategic marburg advanced research and development, preparedness, registration, evaluation and procurement (smart-prep)
Active Definitive Contract Awarded Last action
- Contract number
- 75A50126C00001
- Awardee
-
Albert B. Sabin Vaccine Institute, Inc. (The) UEI H5E8NU6N2HZ5
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $263,613,186
Award facts
- Opportunity
-
- Marburg virus (MARV) and Sudan virus (SUDV) Vaccines Pre-Solicitation · 75A50125R00006 · Posted Jun 27, 2025
- Contract value 25% obligated
-
- $263,613,186.00 Current, with exercised options
- $1,042,099,118.00 Potential, with all options
- Completion date 4% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Washington, DC 20006, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $39,815,002 | |
| Original award | $223,798,184 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a $1.042 billion definitive cost-plus-fixed-fee contract to Albert B. Sabin Vaccine Institute, Inc. for advanced development, licensure, and procurement of vaccines against Marburg virus and Sudan ebolavirus under the Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP) program on May 8, 2026.
The contract extends through April 30, 2036. Place of performance is Washington, DC. The originating solicitation targets late-stage development and FDA Post-Marketing commitments for vaccines against two material health threats with no currently licensed countermeasures; the government requirement encompasses 2.9 million doses of Marburg vaccine and 1.13 million doses of Sudan ebolavirus vaccine for post-exposure prophylaxis. Both filoviruses carry case fatality rates up to 90 percent and have been designated material threats to national security by the Department of Homeland Security. No set-aside was used.
Quick answers
Who was awarded contract 75A50126C00001?
75A50126C00001 was awarded to Albert B. Sabin Vaccine Institute, Inc. (The) by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on May 8, 2026.
How much is contract 75A50126C00001 worth?
The government has obligated $263,613,186 on 75A50126C00001. Its potential value, with all options, is $1,042,099,118.
Was contract 75A50126C00001 competed?
The extent of competition for 75A50126C00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award